SCHEMBL5635575

SCHEMBL5635575

CS(=O)(=O)OCCC1Cc2ccccc2C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.54
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
MMP9 P14780 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CYP19A1 P11511 1/20 0.35
PSEN1 P49768 5/20 0.35
PSEN2 P49810 5/20 0.35
APH1B Q8WW43 5/20 0.35
NCSTN Q92542 5/20 0.35
APH1A Q96BI3 5/20 0.35
PSENEN Q9NZ42 5/20 0.35
KCNH2 Q12809 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
OPRM1 P35372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7214509 0.82 IDO1 (0.41) IDO1ALDH1A1KDM4ECA1CA2
SCHEMBL6883563 0.80 IDO1 (0.47) IDO1ALDH1A1LMNACA1PSEN1
SCHEMBL31634968 0.80 IDO1 (0.47) IDO1ALDH1A1LMNACA1PSEN1
SCHEMBL11837153 0.79 HTR2A (0.46) KCNH2DRD3
SCHEMBL14984399 0.77 PARP11 (0.41) IDO1TSHRNPSR1
SCHEMBL13313179 0.76 IDO1 (0.63) IDO1ALDH1A1KDM4ECYP19A1DRD3
SCHEMBL10827763 0.76 CYP19A1 (0.44) CA1CA2CYP19A1
SCHEMBL10732206 0.76 HTR2A (0.41) ALDH1A1KDM4EUSP2LMNAMMP9
SCHEMBL17838136 0.73 NR1D1 (0.42) ALDH1A1KDM4ENPSR1
SCHEMBL9835750 0.73 DRD2 (0.49) ALDH1A1KDM4EUSP2LMNAMMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39679-E1 Substituted heterocycle fused gamma-carbolines BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-06-05 US disclosed
EP-1192165-B1 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-09-22 EP disclosed
US-6713471-B1 SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-03-30 US disclosed
CN-1370176-A Subsstituted heterocycle fused gamma-carbolines BRISTOL MYERS SQUIBB CO (US) 2002-09-18 CN disclosed
US-5194437-A Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders ADIR ET COMPAGNIE (FR) 1993-03-16 US disclosed